Sotirios Stergiopoulos

Sotirios G.
Stergiopoulos is the founder of A2a Pharmaceuticals, Inc., founded in 2016, where the title held is President & Chief Executive Officer.
Current jobs include Executive Chairman at Coiled Therapeutics Plc and Director at Ricovr Healthcare, Inc. Former jobs include Executive Director-US Medical Affairs Oncology at Celgene Corp.
(2014–2016), Deputy Director-Global Medical Affairs Oncology at Bayer Healthcare LLC (2009–2012), Senior Director-Global Brand Medical at Novartis AG (2012–2014), Independent Director at Biomea Fusion, Inc., Chief Medical Officer & Senior Vice President at Ipsen SA (2017–2019), Vice President & Head-Global Medical Affairs at Shire Plc (2016), Vice President & Head-Global Medical Affairs at Baxalta, Inc. (2016), and Chief Medical Officer & Senior Vice President at Ipsen Pharmaceuticals, Inc. (2017–2019).
Education includes undergraduate studies at Stony Brook University, graduate studies at The Johns Hopkins University, and a doctorate from Poznan University of Medical Science.